Zobair Younossi, Chairman of the Global NASH/MASH Council and Professor of Medicine at Georgetown University, reviewed the latest global consensus recommendations for the diagnosis and management of Metabolic dysfunction-associated steatotic liver disease and Metabolic dysfunction-associated steatohepatitis. The updated recommendations were developed through a systematic literature review and Delphi consensus process involving approximately 290 experts from 65 countries, with the goal of harmonizing international guidance and providing a practical framework for everyday clinical care.
Keep Reading
Add A Comment
